• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基层医疗中痛风管理的挑战:最佳实践审核结果。

The challenges of managing gout in primary care: Results of a best-practice audit.

机构信息

MBChB, FRACP, PhD, Professor and Rheumatologist, Department of Medicine, University of Otago, Christchurch, NZ.

MBChB, MD, FRACP, Rheumatologist, Department of Rheumatology, Immunology and Allergy, Christchurch Hospital, Christchurch, NZ.

出版信息

Aust J Gen Pract. 2019 Sep;48(9):631-637. doi: 10.31128/AJGP-04-19-4909.

DOI:10.31128/AJGP-04-19-4909
PMID:31476837
Abstract

BACKGROUND AND OBJECTIVES

The aim of this project was to determine the effects of a package of care for gout in primary care.

METHOD

An audit of gout management in a single rural medical practice was undertaken before (in 2012) and after (in 2015) the introduction of the package of care reflecting guidelines in gout management.

RESULTS

There was a statistically significant increase in the number of individuals commenced on allopurinol ≤100 mg/d and a decrease in the number commenced on allopurinol ≥200 mg/d (P <0.001). The number of times each patient had serum urate tested between 2012 and 2015 (median [range] 1 [0-3] versus 2 [0-10], respectively; P <0.001). Of those individuals who had at least one serum urate measurement, the number of individuals who were never at target urate was 43 out of 67 (64.2%) in 2012, compared with 52 out of 133 (39.1%) in 2015 (P = 0.001).

DISCUSSION

A package of care can improve adherence to gout management guidelines in primary care.

摘要

背景与目的

本项目旨在确定初级保健中痛风综合护理包的效果。

方法

在引入反映痛风管理指南的综合护理包之前(2012 年)和之后(2015 年),对单一农村医疗实践中的痛风管理进行了审核。

结果

开始使用≤100mg/d 别嘌醇的人数呈统计学显著增加,而开始使用≥200mg/d 别嘌醇的人数减少(P<0.001)。每位患者在 2012 年至 2015 年期间进行血清尿酸检测的次数(中位数[范围]:1[0-3]次与 2[0-10]次;P<0.001)。在至少进行过一次血清尿酸测量的患者中,2012 年有 67 例患者中从未达到目标尿酸水平的有 43 例(64.2%),而 2015 年有 133 例患者中从未达到目标尿酸水平的有 52 例(39.1%)(P=0.001)。

讨论

综合护理包可以提高初级保健中痛风管理指南的依从性。

相似文献

1
The challenges of managing gout in primary care: Results of a best-practice audit.基层医疗中痛风管理的挑战:最佳实践审核结果。
Aust J Gen Pract. 2019 Sep;48(9):631-637. doi: 10.31128/AJGP-04-19-4909.
2
Opportunities for improving medication use and monitoring in gout.改善痛风药物使用及监测的机会。
Ann Rheum Dis. 2009 Aug;68(8):1265-70. doi: 10.1136/ard.2008.092619. Epub 2008 Aug 13.
3
Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.根据肌酐清除率调整别嘌醇剂量并不能充分控制痛风患者的高尿酸血症。
J Rheumatol. 2006 Aug;33(8):1646-50.
4
Major unanswered questions in the clinical gout field.临床痛风领域的重大未解决问题。
Curr Opin Rheumatol. 2017 Mar;29(2):171-177. doi: 10.1097/BOR.0000000000000367.
5
Burden and management of gout in a multi-ethnic Asian cohort.多民族亚洲队列中痛风的负担和管理。
Rheumatol Int. 2020 Jul;40(7):1029-1035. doi: 10.1007/s00296-019-04475-6. Epub 2019 Nov 22.
6
CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts.病例挑战:痛风、高尿酸血症及其合并症的管理——与专家对话。
Am J Med. 2014 Jan;127(1):S1. doi: 10.1016/j.amjmed.2013.11.001. Epub 2013 Nov 19.
7
GOSPEL 3: Management of gout by primary-care physicians and office-based rheumatologists in France in the early 21st century - comparison with 2006 EULAR Recommendations.福音书3:21世纪初法国基层医疗医生和门诊风湿病专家对痛风的管理——与2006年欧洲抗风湿病联盟建议的比较
Joint Bone Spine. 2017 Jul;84(4):447-453. doi: 10.1016/j.jbspin.2017.04.002. Epub 2017 Apr 12.
8
Treatment of gout.痛风的治疗。
Intern Med J. 2011 Jan;41(1a):70-1. doi: 10.1111/j.1445-5994.2010.02387.x.
9
Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.非布司他与别嘌醇及安慰剂对高尿酸血症和痛风患者降低血清尿酸的作用:一项为期28周的III期随机双盲平行组试验。
Arthritis Rheum. 2008 Nov 15;59(11):1540-8. doi: 10.1002/art.24209.
10
Effect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trials.降尿酸治疗起始后预防性治疗对痛风发作的影响:三项 III 期临床试验数据分析。
Clin Ther. 2010 Dec;32(14):2386-97. doi: 10.1016/j.clinthera.2011.01.008.

引用本文的文献

1
Easing the way to achieving target serum urate in people with gout: protocol for a non-inferiority randomised strategy trial using an allopurinol dosing model in Aotearoa/New Zealand (the Easy-Allo Study).缓解痛风患者达到目标血清尿酸水平的方法:在新西兰(Easy-Allo 研究)使用别嘌醇剂量模型进行非劣效性随机策略试验的方案。
BMJ Open. 2024 Aug 3;14(8):e084665. doi: 10.1136/bmjopen-2024-084665.
2
Management of gout in the primary care setting.基层医疗环境中痛风的管理。
Malays Fam Physician. 2022 Feb 20;17(1):2-9. doi: 10.51866/rv1165. eCollection 2022 Mar 28.
3
Interventions to improve uptake of urate-lowering therapy in patients with gout: a systematic review.
改善痛风患者降尿酸治疗接受率的干预措施:一项系统评价
BJGP Open. 2020 Aug 25;4(3). doi: 10.3399/bjgpopen20X101051. Print 2020 Aug.